HydroGraph Clean Power Inc. announced that its graphene product, FGA-1, has been successfully trialed in Hawkeye Bio's biomedical sensor aimed at the early detection of lung cancer. The global biosensor market is expected to reach USD 60 billion by 2032. HydroGraph's graphene, the third company to be certified globally by the Graphene Council, was selected by Hawkeye Bio based on the purity and consistency of its graphene.

Headquartered in Toronto, HydroGraph's manufacturing facility is located in Manhattan, Kan.